PLIVA FDA Approval ANDA 074421

ANDA 074421

PLIVA

FDA Drug Application

Application #074421

Application Sponsors

ANDA 074421PLIVA

Marketing Status

Prescription001

Application Products

001TABLET;ORAL10MG0CYCLOBENZAPRINE HYDROCHLORIDECYCLOBENZAPRINE HYDROCHLORIDE

FDA Submissions

ORIG1AP1995-09-29
MANUF (CMC); Manufacturing (CMC)SUPPL2AP2000-07-07
MANUF (CMC); Manufacturing (CMC)SUPPL3AP2000-11-20
MANUF (CMC); Manufacturing (CMC)SUPPL4AP2001-03-16
MANUF (CMC); Manufacturing (CMC)SUPPL5AP2001-05-29
LABELING; LabelingSUPPL21AP2010-03-16
MANUF (CMC); Manufacturing (CMC)SUPPL32AP2013-04-02UNKNOWN
LABELING; LabelingSUPPL33AP2013-04-11STANDARD

Submissions Property Types

SUPPL1Null0
SUPPL2Null0
SUPPL3Null0
SUPPL4Null0
SUPPL5Null0
SUPPL32Null7
SUPPL33Null15

TE Codes

001PrescriptionAB

CDER Filings

PLIVA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 74421
            [companyName] => PLIVA
            [docInserts] => ["",""]
            [products] => [{"drugName":"CYCLOBENZAPRINE HYDROCHLORIDE","activeIngredients":"CYCLOBENZAPRINE HYDROCHLORIDE","strength":"10MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"CYCLOBENZAPRINE HYDROCHLORIDE","submission":"CYCLOBENZAPRINE HYDROCHLORIDE","actionType":"10MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.